ARS Pharmaceuticals, Inc. (SPRY)
3.66
+0.01
(+0.27%)
USD |
NASDAQ |
Oct 29, 16:00
3.655
0.00 (0.00%)
Pre-Market: 20:00
ARS Pharmaceuticals Cash and Short Term Investments (Annual) : 244.99M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 244.99M |
| December 31, 2024 | 314.02M |
| December 31, 2023 | 228.36M |
| December 31, 2022 | 274.38M |
| Date | Value |
|---|---|
| December 31, 2021 | 60.06M |
| December 31, 2020 | 386.57M |
| December 31, 2019 | 9.976M |
| December 31, 2018 | 20.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Capricor Therapeutics, Inc. | 318.13M |
| Sionna Therapeutics, Inc. | 235.88M |
| Nektar Therapeutics | 245.75M |
| Ardelyx, Inc. | 264.69M |
| Kyntra Bio, Inc. | 88.98M |